Study of Aspirin and TPA in Acute Ischemic Stroke

Withdrawn

Phase 1 Results N/A

Summary of Purpose

This study will determine the safety of 500mg of aspirin added to IV TPA at standard doses to prevent re-occlusion of cerebral vessels after successful reperfusion. In ischemic stroke brain arteries are occluded either by an embolus originating in the heart or large vessels leading to the brain or by a process of acute thrombosis of the cerebral arteries over a ruptured atherosclerotic plaque. Rupture of the...

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 1 September 2016.

1 Mar 2007 2 Jan 2007 Unavailable 1 Dec 2012 1 Jan 2007 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Design

  • Allocation: Randomized
  • Masking: Open Label
  • Purpose: Treatment
  • Endpoint: Safety/Efficacy Study
  • Intervention: Parallel Assignment

Contacts